<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns:p="http://www.sec.gov/edgar/schedule13g" xmlns:p1="http://www.sec.gov/edgar/common"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><link rel="stylesheet" type="text/css" href="/css/SDR_print.css"><style type="text/css">
					.fakeTextBox {
					border-top: 2px solid #999;
					border-right: 1px solid #ccc;
					border-bottom: 1px solid #ccc;
					border-left: 2px solid #999;
					padding: 2px;
					_width: 800px;
					height: auto;
					min-width: 200px;
					min-height: 50px;
					word-wrap: break-word;
					font-size: 0.9em;
					color: blue;
					}
				</style><style type="text/css">
					table.tableClass { border: solid black;
					border-top-width: 1;
					border-right-width: 1;
					border-bottom-width: 1;
					border-left-width: 1;
					table-layout:fixed;
					}
					table.innerTableClass { border: solid black;
					border-top-width: 0;
					border-right-width: 0;
					border-bottom-width: 0;
					border-left-width: 0;
					table-layout:fixed;
					}
					table.collapsabletableClass { 
					border-collapse:collapse; 
					border-top-width: 0;
					border-right-width: 0;
					border-bottom-width: 0;
					border-left-width: 0;
					table-layout:fixed;
					}
					th.tableClassLeft { border: solid black;
					border-top-width: 0px;
					border-right-width: 0px;
					border-bottom-width: 1px;
					border-left-width: 1px;
					padding: 2px;
					}
					th.tableClassRight { border: solid black;
					border-top-width: 0px;
					border-right-width: 1px;
					border-bottom-width: 1px;
					border-left-width: 0;
					padding: 2px;
					}
					th.tableClass { border: solid black;
					border-top-width: 0px;
					border-right-width: 1px;
					border-bottom-width: 1px;
					border-left-width: 1px;
					padding: 2px;
					}
					td.tableClassLeft { border: solid black;
					border-top-width: 0px;
					border-right-width: 0px;
					border-bottom-width: 1px;
					border-left-width: 1px;
					font-size: 0.9em;
					color: blue;
					word-wrap: break-word;
					}
					td.tableClassRight { border: solid black;
					border-top-width: 0px;
					border-right-width: 1px;
					border-bottom-width: 1px;
					border-left-width: 0;
					font-size: 0.9em;
					color: blue;
					word-wrap: break-word;
					}
					td.tableClass { border: solid black;
					border-top-width: 0px;
					border-right-width: 1px;
					border-bottom-width: 1px;
					border-left-width: 1px;
					font-size: 0.9em;
					font-weight:bold;
					color: black;
					word-wrap: break-word;
					}
					td.tableClassNoBorder { border: solid black;
					border-top-width: 0px;
					border-right-width: 0px;
					border-bottom-width: 0px;
					border-left-width: 0px;
					font-size: 0.9em;
					font-weight:bold;
					color: black;
					word-wrap: break-word;
					}
					
					td.tableClassNoBorderBlue { border: solid black;
					border-top-width: 0px;
					border-right-width: 0px;
					border-bottom-width: 0px;
					border-left-width: 0px;
					font-size: 0.9em;
					font-weight:bold;
					color: blue;
					word-wrap: break-word;
					}
					
					td.tableClassInnerNoBorderBlue { border: solid black;
					border-top-width: 0px;
					border-right-width: 0px;
					border-bottom-width: 0px;
					border-left-width: 0px;
					font-size: 1.4em;
					font-weight:bold;
					color: blue;
					word-wrap: break-word;
					}
					
					td.tableClassNoBorderAlignLeft { border: solid black;
					border-top-width: 0px;
					border-right-width: 0px;
					border-bottom-width: 0px;
					border-left-width: 0px;
					font-size: 0.9em;
					font-weight:bold;
					text-align: left;
					color: black;
					word-wrap: break-word;
					}
					
					td.signature {
					padding: 4px 8px;
					}
					
					td.tableClassInner { border: solid black;
					border-top-width: 0px;
					border-right-width: 1px;
					border-bottom-width: 1px;
					border-left-width: 1px;
					font-size: 1em;
					font-weight:bold;
					color: black;
					word-wrap: break-word;
					}
					
					td.tableClassValign { border: solid black;
					border-top-width: 0px;
					border-right-width: 1px;
					border-bottom-width: 1px;
					border-left-width: 1px;
					font-size: 0.9em;
					font-weight:bold;
					color: black;
					vertical-align: middle;
					text-align: center;
					word-wrap: break-word;
					}
					
					td.tableClassValignNoBorder { border: solid black;
					border-top-width: 0px;
					border-right-width: 0px;
					border-bottom-width: 0px;
					border-left-width: 0px;
					font-size: 0.9em;
					font-weight:bold;
					color: black;
					vertical-align: middle;
					text-align: center;
					word-wrap: break-word;
					}
					
					td.tableClassValignInner { border: solid black;
					border-top-width: 0px;
					border-right-width: 1px;
					border-bottom-width: 1px;
					border-left-width: 1px;
					font-size: 1em;
					font-weight:bold;
					color: black;
					vertical-align: middle;
					text-align: center;
					word-wrap: break-word;
					}
					
					td.innerTableClassRightValign { border: solid black;
					border-top-width: 0px;
					border-right-width: 1px;
					border-bottom-width: 1px;
					border-left-width: 0;
					font-size: 1em;
					font-weight:bold;
					color: black;
					vertical-align: middle;
					text-align: center;
					word-wrap: break-word;
					}
					
					td.innerTableClassRightValignBottomLess { border: solid black;
					border-top-width: 0px;
					border-right-width: 1px;
					border-bottom-width: 0px;
					border-left-width: 0;
					font-size: 1em;
					font-weight:bold;
					color: black;
					vertical-align: middle;
					text-align: center;
					word-wrap: break-word;
					}
					
					td.tableClassInnerLeft { border: solid black;
					border-top-width: 0px;
					border-right-width: 0px;
					border-bottom-width: 1px;
					border-left-width: 1px;
					font-size: 1em;
					font-weight:bold;
					color: black;
					word-wrap: break-word;
					}
					
					td.tableClassInnerLeftBottomLess { border: solid black;
					border-top-width: 0px;
					border-right-width: 0px;
					border-bottom-width: 0px;
					border-left-width: 1px;
					font-size: 1em;
					font-weight:bold;
					color: black;
					word-wrap: break-word;
					}
					
					td.tableClassNoBorderAlignCenter { border: solid black;
					border-top-width: 0px;
					border-right-width: 0px;
					border-bottom-width: 0px;
					border-left-width: 0px;
					font-size: 0.9em;
					font-weight:bold;
					color: black;
					text-align: center;
					word-wrap: break-word;
					}
					
					tr.tableClass { border: solid black;
					border-top-width: 1px;
					border-right-width: 1px;
					border-bottom-width: 1px;
					border-left-width: 1px;
					}
					tr.tableClassWithBg { border: solid black;
					border-top-width: 0;
					border-right-width: 1;
					border-bottom-width: 1;
					border-left-width: 0;
					background-color: #e0e0ff
					}
					
					tr.tableClassWithBgBlack { border: solid black;
					border-top-width: 0;
					border-right-width: 1;
					border-bottom-width: 1;
					border-left-width: 0;
					background-color: #D3D3D3
					}
					
					hr.header {
        			position: relative;
        			top: 20px;
        			border: none;
        			height: 6px;
        			background: black;
        			margin-bottom: 10px;
    				}
    				
    				hr.separatorThin {
        			position: relative;
        			top: 2px;
        			border: none;
        			height: 2px;
        			background: black;
        			margin-bottom: 2px;
    				}
					
					hr.headerThin {
        			position: relative;
        			top: 10px;
        			border: none;
        			height: 2px;
        			background: black;
        			margin-bottom: 10px;
    				}
    				
					hr.separator {
        			position: relative;
        			top: 20px;
        			border: none;
        			height: 4px;
        			background: black;
        			margin-bottom: 5px;
    				}
    				
    				div.text {
  						background-color: #ffffff;
  						color: blue;
  						font-size: 1em;
  						font-weight:normal;
  						text-align:justify;
					}
					
					div.largetext {
  						background-color: #ffffff;
  						color: blue;
  						font-size: 1em;
  						font-weight:normal;
  						text-align:justify;
  						white-space: pre-wrap;
					}
					
					
					div.information {
  						background-color: #ffffff;
  						color: black;
  						font-size: 1em;
  						font-weight:normal;
  						text-align:justify;
					}
					
					#scheader {
						font-size: 0.9em;
						border: 0px solid #404040;
						border-spacing: 2px;
					}
					
				</style></head><body lang="en-US" text="#000000" bgcolor="#ffffff"><hr class="header"><br><hr class="headerThin"><div class="contentwrapper"><table role="presentation" id="scheader"><tr><td class="tableClassNoBorderAlignCenter" style="font-size:2em;">
						SECURITIES AND EXCHANGE COMMISSION
						<br>
						Washington, D.C. 20549
					</td></tr><tr><td class="tableClassNoBorderAlignCenter"><br><br><div style="font-size:1.5em;">
									SCHEDULE 13G
								</div><br><br></td></tr><tr><td class="tableClassNoBorderAlignCenter"><div style="font-size:1.2em;">
							UNDER THE SECURITIES EXCHANGE ACT OF 1934
					</div></td></tr><tr><td class="center"><div class="information" style="text-align:center; font-weight:bold;">
									(Amendment No. <span style="color:blue;">3</span>)
								</div><br><br></td></tr><tr><td class="center"><div class="information" style="text-align:center; font-weight:bold; color:blue;">LifeStance Health Group, Inc.</div><div class="information" style="text-align:center; font-weight:bold;"><hr class="separatorThin">(Name of Issuer)</div><br><br></td></tr><tr><td class="center"><div class="information" style="text-align:center; font-weight:bold; color:blue;">Common Stock, par value $0.01 per share</div><div class="information" style="text-align:center; font-weight:bold;"><hr class="separatorThin">(Title of Class of Securities)</div><br><br></td></tr><table border="1"><tr><td><div class="information" style="text-align:center; font-weight:bold; color:blue;">53228F101</div><div class="information" style="text-align:center; font-weight:bold;"><hr class="separatorThin">(CUSIP Number)</div></td></tr><br><br></table><tr><td class="center"><div class="information" style="text-align:center; font-weight:bold; color:blue;">06/30/2026</div><div class="information" style="text-align:center; font-weight:bold;"><hr class="separatorThin">(Date of Event Which Requires Filing of this Statement)</div></td></tr></table><br><br><table><tr><td class="label"> Check the appropriate box to designate the rule pursuant to which this Schedule is filed:</td></tr><tr><td><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked">   Rule 13d-1(b)
					</td></tr><tr><td><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked">   Rule 13d-1(c)
					</td></tr><tr><td><img src="/Images/box-checked.jpg" alt="Checkbox checked">   Rule 13d-1(d)
				</td></tr></table></div><hr class="headerThin"><hr class="header"><br><br>
  <div style="display:none">
			schemaVersion:
			</div>
<div class="content"><div class="form1"></div></div>
  <div class="content"><div class="form1"><table><tr><td class="center"><br><br><p><div align="center" style="font-size:1.2em;">
								SCHEDULE 13G
							</div></p></td></tr></table><table role="presentation" class="tableClass" id="cusipNumber"><tr class="tableClass"><td width="7%" style="font-weight:bold;">CUSIP Number(s):</td><td width="75%"><div style="font-size:.9em; color:#000000">53228F101</div></td></tr></table><br><br><table role="presentation" class="tableClass" id="reportingPersonDetails"><tr class="tableClass"><td width="8%" class="tableClassValign">1</td><td width="92%" class="tableClass">Names of Reporting Persons
				<br><br><div class="text">TPG GP A, LLC</div></td></tr><tr><td width="8%" class="tableClassValign">2</td><td width="92%" class="tableClass">Check the appropriate box if a member of a Group (see instructions)
				<br><br><div class="text"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked">  (a)
					<br><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked">  (b)	
				</div></td></tr><tr class="tableClassWithBgBlack"><td width="8%" class="tableClassValign">3</td><td width="92%" class="tableClass">Sec Use Only</td></tr><tr><td width="8%" class="tableClassValign">4</td><td width="92%" class="tableClass">Citizenship or Place of Organization
				<br><br><div class="text">
				DELAWARE
			</div></td></tr><tr><td width="8%" class="tableClassValign">Number of Shares Beneficially Owned by Each Reporting Person With:</td><td width="92%" class="tableClass"><table class="innerTableClass"><tr><td width="8%" class="innerTableClassRightValign">5</td><td width="92%" class="tableClassInnerLeft">Sole Voting Power
							<br><br><div class="text">0.00</div></td></tr><tr><td width="8%" class="innerTableClassRightValign">6</td><td width="92%" class="tableClassInnerLeft">Shared Voting Power
							<br><br><div class="text">98,101,407.00</div></td></tr><tr><td width="8%" class="innerTableClassRightValign">7</td><td width="92%" class="tableClassInnerLeft">Sole Dispositive Power
							<br><br><div class="text">0.00</div></td></tr><tr><td width="8%" class="innerTableClassRightValignBottomLess">8</td><td width="92%" class="tableClassInnerLeftBottomLess">Shared Dispositive Power
							<br><br><div class="text">98,101,407.00</div></td></tr></table></td></tr><tr><td width="8%" class="tableClassValign">9</td><td width="92%" class="tableClass">Aggregate Amount Beneficially Owned by Each Reporting Person
				<br><br><div class="text">98,101,407.00</div></td></tr><tr><td width="8%" class="tableClassValign">10</td><td width="92%" class="tableClass">Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
				<br><br><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"></td></tr><tr><td width="8%" class="tableClassValign">11</td><td width="92%" class="tableClass">Percent of class represented by amount in row (9)
				<br><br><div class="text">25.7 % </div></td></tr><tr><td width="8%" class="tableClassValign">12</td><td width="92%" class="tableClass">Type of Reporting Person (See Instructions)
				<br><br><div class="text">OO</div></td></tr></table><br><div class="largetext"><span style="color:black;font-weight:bold;">Comment for Type of Reporting Person:</span>  The percentage beneficial ownership set forth in response to Item 11 above is based on 382,055,609 shares of Common Stock (as defined below) outstanding as of July 29, 2026, as reported on the Quarterly Report on Form 10-Q filed by LifeStance Health Group, Inc. (the "Issuer") with the Securities and Exchange Commission (the "Commission") on August 6, 2026.</div><table><tr><td class="center"><br><br><p><div align="center" style="font-size:1.2em;">
								SCHEDULE 13G
							</div></p></td></tr></table><table role="presentation" class="tableClass" id="cusipNumber"><tr class="tableClass"><td width="7%" style="font-weight:bold;">CUSIP Number(s):</td><td width="75%"><div style="font-size:.9em; color:#000000">53228F101</div></td></tr></table><br><br><table role="presentation" class="tableClass" id="reportingPersonDetails"><tr class="tableClass"><td width="8%" class="tableClassValign">1</td><td width="92%" class="tableClass">Names of Reporting Persons
				<br><br><div class="text">COULTER, JAMES G</div></td></tr><tr><td width="8%" class="tableClassValign">2</td><td width="92%" class="tableClass">Check the appropriate box if a member of a Group (see instructions)
				<br><br><div class="text"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked">  (a)
					<br><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked">  (b)	
				</div></td></tr><tr class="tableClassWithBgBlack"><td width="8%" class="tableClassValign">3</td><td width="92%" class="tableClass">Sec Use Only</td></tr><tr><td width="8%" class="tableClassValign">4</td><td width="92%" class="tableClass">Citizenship or Place of Organization
				<br><br><div class="text">
				UNITED STATES
			</div></td></tr><tr><td width="8%" class="tableClassValign">Number of Shares Beneficially Owned by Each Reporting Person With:</td><td width="92%" class="tableClass"><table class="innerTableClass"><tr><td width="8%" class="innerTableClassRightValign">5</td><td width="92%" class="tableClassInnerLeft">Sole Voting Power
							<br><br><div class="text">0.00</div></td></tr><tr><td width="8%" class="innerTableClassRightValign">6</td><td width="92%" class="tableClassInnerLeft">Shared Voting Power
							<br><br><div class="text">98,101,407.00</div></td></tr><tr><td width="8%" class="innerTableClassRightValign">7</td><td width="92%" class="tableClassInnerLeft">Sole Dispositive Power
							<br><br><div class="text">0.00</div></td></tr><tr><td width="8%" class="innerTableClassRightValignBottomLess">8</td><td width="92%" class="tableClassInnerLeftBottomLess">Shared Dispositive Power
							<br><br><div class="text">98,101,407.00</div></td></tr></table></td></tr><tr><td width="8%" class="tableClassValign">9</td><td width="92%" class="tableClass">Aggregate Amount Beneficially Owned by Each Reporting Person
				<br><br><div class="text">98,101,407.00</div></td></tr><tr><td width="8%" class="tableClassValign">10</td><td width="92%" class="tableClass">Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
				<br><br><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"></td></tr><tr><td width="8%" class="tableClassValign">11</td><td width="92%" class="tableClass">Percent of class represented by amount in row (9)
				<br><br><div class="text">25.7 % </div></td></tr><tr><td width="8%" class="tableClassValign">12</td><td width="92%" class="tableClass">Type of Reporting Person (See Instructions)
				<br><br><div class="text">IN</div></td></tr></table><br><div class="largetext"><span style="color:black;font-weight:bold;">Comment for Type of Reporting Person:</span>  The percentage beneficial ownership set forth in response to Item 11 above is based on 382,055,609 shares of Common Stock outstanding as of July 29, 2026, as reported on the Quarterly Report on Form 10-Q filed by the Issuer with the Commission on August 6, 2026.</div><table><tr><td class="center"><br><br><p><div align="center" style="font-size:1.2em;">
								SCHEDULE 13G
							</div></p></td></tr></table><table role="presentation" class="tableClass" id="cusipNumber"><tr class="tableClass"><td width="7%" style="font-weight:bold;">CUSIP Number(s):</td><td width="75%"><div style="font-size:.9em; color:#000000">53228F101</div></td></tr></table><br><br><table role="presentation" class="tableClass" id="reportingPersonDetails"><tr class="tableClass"><td width="8%" class="tableClassValign">1</td><td width="92%" class="tableClass">Names of Reporting Persons
				<br><br><div class="text">WINKELRIED, JON</div></td></tr><tr><td width="8%" class="tableClassValign">2</td><td width="92%" class="tableClass">Check the appropriate box if a member of a Group (see instructions)
				<br><br><div class="text"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked">  (a)
					<br><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked">  (b)	
				</div></td></tr><tr class="tableClassWithBgBlack"><td width="8%" class="tableClassValign">3</td><td width="92%" class="tableClass">Sec Use Only</td></tr><tr><td width="8%" class="tableClassValign">4</td><td width="92%" class="tableClass">Citizenship or Place of Organization
				<br><br><div class="text">
				UNITED STATES
			</div></td></tr><tr><td width="8%" class="tableClassValign">Number of Shares Beneficially Owned by Each Reporting Person With:</td><td width="92%" class="tableClass"><table class="innerTableClass"><tr><td width="8%" class="innerTableClassRightValign">5</td><td width="92%" class="tableClassInnerLeft">Sole Voting Power
							<br><br><div class="text">0.00</div></td></tr><tr><td width="8%" class="innerTableClassRightValign">6</td><td width="92%" class="tableClassInnerLeft">Shared Voting Power
							<br><br><div class="text">98,101,407.00</div></td></tr><tr><td width="8%" class="innerTableClassRightValign">7</td><td width="92%" class="tableClassInnerLeft">Sole Dispositive Power
							<br><br><div class="text">0.00</div></td></tr><tr><td width="8%" class="innerTableClassRightValignBottomLess">8</td><td width="92%" class="tableClassInnerLeftBottomLess">Shared Dispositive Power
							<br><br><div class="text">98,101,407.00</div></td></tr></table></td></tr><tr><td width="8%" class="tableClassValign">9</td><td width="92%" class="tableClass">Aggregate Amount Beneficially Owned by Each Reporting Person
				<br><br><div class="text">98,101,407.00</div></td></tr><tr><td width="8%" class="tableClassValign">10</td><td width="92%" class="tableClass">Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
				<br><br><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"></td></tr><tr><td width="8%" class="tableClassValign">11</td><td width="92%" class="tableClass">Percent of class represented by amount in row (9)
				<br><br><div class="text">25.7 % </div></td></tr><tr><td width="8%" class="tableClassValign">12</td><td width="92%" class="tableClass">Type of Reporting Person (See Instructions)
				<br><br><div class="text">IN</div></td></tr></table><br><div class="largetext"><span style="color:black;font-weight:bold;">Comment for Type of Reporting Person:</span>  The percentage beneficial ownership set forth in response to Item 11 above is based on 382,055,609 shares of Common Stock outstanding as of July 29, 2026, as reported on the Quarterly Report on Form 10-Q filed by the Issuer with the Commission on August 6, 2026.</div></div><div class="form1"><table><tr><td class="center"><br><br><p><div align="center" style="font-size:1.2em;">
								SCHEDULE 13G
							</div></p></td></tr></table><table role="presentation" id="item1to9"><tr><td width="8%" class="tableClassValignNoBorder">Item 1.</td><td width="92%" class="tableClassNoBorder"> </td></tr><tr class="tableClass"><td width="8%" class="tableClassNoBorderAlignCenter">(a)</td><td width="92%" class="tableClassNoBorder">Name of issuer:
					<br><br><div class="text">LifeStance Health Group, Inc.</div></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(b)</td><td width="92%" class="tableClassNoBorder">Address of issuer's principal executive offices:
					<br><br><div class="text">4800 N. Scottsdale Road, Suite 2500, Scottsdale, AZ 85251</div></td></tr><tr><td width="8%" class="tableClassValignNoBorder">Item 2.</td><td width="92%" class="tableClassNoBorder"> </td></tr><tr class="tableClass"><td width="8%" class="tableClassNoBorderAlignCenter">(a)</td><td width="92%" class="tableClassNoBorder">Name of person filing:
					<br><br><div class="largetext">This Amendment No. 3 to Schedule 13G is being filed jointly by TPG GP A, LLC, a Delaware limited liability company ("TPG GP A"), James G. Coulter and Jon Winkelried (each, a "Reporting Person" and, together, the "Reporting Persons"), pursuant to an Agreement of Joint Filing incorporated by reference herein in accordance with Rule 13d-1(k)(1) under the Act.

TPG GP A exercises direct or indirect control over entities that collectively hold 100% of the shares of Class B common stock (which represents a majority of the combined voting power of the common stock) of TPG Inc., a Delaware corporation, which is the sole member of TPG GPCo, LLC, a Delaware limited liability company, which is the sole member of TPG Holdings II-A, LLC, a Delaware limited liability company, which is the general partner of TPG Operating Group II, L.P., a Delaware limited partnership, which is the sole member of TPG Holdings I-A, LLC, a Delaware limited liability company, which is the general partner of TPG Operating Group I, L.P., a Delaware limited partnership, which is the sole member of TPG GenPar VIII Advisors, LLC, a Delaware limited liability company, which is the general partner of TPG GenPar VIII, L.P., a Delaware limited partnership, which is the general partner of TPG VIII Lynnwood Holdings Aggregation, L.P., a Delaware limited partnership ("TPG VIII Lynnwood"), which directly holds 98,101,407 shares of Common Stock.

Because of the relationship of TPG GP A to TPG VIII Lynnwood, TPG GP A may be deemed to be the beneficial owner of the shares of Common Stock held by TPG VIII Lynnwood. TPG GP A is controlled by entities owned by Messrs. Coulter and Winkelried. Because of the relationship of Messrs. Coulter and Winkelried to TPG GP A, each of Messrs. Coulter and Winkelried may be deemed to be the beneficial owners of the shares of Common Stock held by TPG VIII Lynnwood. Messrs. Coulter and Winkelried disclaim beneficial ownership of such shares of Common Stock held by TPG VIII Lynnwood except to the extent of their pecuniary interest therein.</div></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(b)</td><td width="92%" class="tableClassNoBorder">Address or principal business office or, if none, residence:
					<br><br><div class="largetext">The principal business address of each of the Reporting Persons is as follows:

c/o TPG Inc.
301 Commerce Street, Suite 3300
Fort Worth, Texas 76102</div></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(c)</td><td width="92%" class="tableClassNoBorder">Citizenship:
					<br><br><div class="largetext">See response to Item 4 of each of the cover pages.</div></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(d)</td><td width="92%" class="tableClassNoBorder">Title of class of securities:
					<br><br><div class="text">Common Stock, par value $0.01 per share</div></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(e)</td><td width="92%" class="tableClassNoBorder">CUSIP No.:
					<br><br><div class="text">53228F101</div></td></tr><tr><td width="8%" class="tableClassValignNoBorder">Item 3.</td><td width="92%" class="tableClassNoBorder">If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(a)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked">   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
					</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(b)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked">   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
					</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(c)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked">   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
					</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(d)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked">   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
					</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(e)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked">   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
					</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(f)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked">   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
					</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(g)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked">   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
					</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(h)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked">   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
					</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(i)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked">   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
					</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(j)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked">   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), 
						<br>       please specify the type of institution:
					</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(k)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked">   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
					</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="100%" colspan="2" class="tableClassNoBorder"><div class="largetext"></div></td></tr><tr><td width="8%" class="tableClassValignNoBorder">Item 4.</td><td width="92%" class="tableClassNoBorder">Ownership</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(a)</td><td width="92%" class="tableClassNoBorder">Amount beneficially owned:
					<br><br><div class="largetext">See responses to Item 9 on each cover page.</div></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(b)</td><td width="92%" class="tableClassNoBorder">Percent of class:
					<br><br><div class="largetext">See responses to Item 11 on each cover page.</div></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(c)</td><td width="92%" class="tableClassNoBorder">Number of shares as to which the person has:
					<br></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder">(i) Sole power to vote or to direct the vote:
					<br><br><div class="largetext">See responses to Item 5 on each cover page.</div><br></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder">(ii) Shared power to vote or to direct the vote:
					<br><br><div class="largetext">See responses to Item 6 on each cover page.</div><br></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder">(iii) Sole power to dispose or to direct the disposition of:
					<br><br><div class="largetext">See responses to Item 7 on each cover page.</div><br></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder">(iv) Shared power to dispose or to direct the disposition of:
					<br><br><div class="largetext">See responses to Item 8 on each cover page.</div><br></td></tr><tr><td width="8%" class="tableClassValignNoBorder">Item 5.</td><td width="92%" class="tableClassNoBorder">Ownership of 5 Percent or Less of a Class.</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder"><div class="text">
								Not Applicable
							</div></td></tr><tr><td width="8%" class="tableClassValignNoBorder">Item 6.</td><td width="92%" class="tableClassNoBorder">Ownership of more than 5 Percent on Behalf of Another Person.</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder"><div class="text">
							Not Applicable
						</div></td></tr><tr><td width="8%" class="tableClassValignNoBorder">Item 7.</td><td width="92%" class="tableClassNoBorder">Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder"><div class="information" style="text-align:justify">
							If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
						</div><br><br><div class="largetext">See response to Item 2(a) above.</div></td></tr><tr><td width="8%" class="tableClassValignNoBorder">Item 8.</td><td width="92%" class="tableClassNoBorder">Identification and Classification of Members of the Group.</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder"><div class="information" style="text-align:justify">
								If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
							</div><br><br><div class="largetext">TPG VIII Lynnwood entered into a Stockholders Agreement, dated as of June 9, 2021, with certain other holders (the "Holders") of shares of Common Stock. Pursuant to the Stockholders Agreement, TPG VIII Lynnwood and the Holders have agreed to, among other things, vote their shares of Common Stock to elect members of the Board of Directors of the Issuer as set forth therein.

Because of the relationship between TPG VIII Lynnwood and the Holders as a result of the Stockholders Agreement, the Reporting Persons may be deemed, pursuant to Rule 13d-3 under the Act, to beneficially own the shares of Common Stock beneficially owned by TPG VIII Lynnwood and the Holders and/or to constitute a "group" with the Holders. Each Reporting Person and TPG VIII Lynnwood disclaims beneficial ownership of the shares of Common Stock beneficially owned by the Holders, except to the extent of its pecuniary interest therein, if any.</div></td></tr><tr><td width="8%" class="tableClassValignNoBorder">Item 9.</td><td width="92%" class="tableClassNoBorder">Notice of Dissolution of Group.</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder"><div class="text">
									Not Applicable
								</div></td></tr></table><br></div><div class="form1"><table role="presentation" id="certifications"><tr><td width="8%" class="tableClassValignNoBorder">Item 10.</td><td width="92%" class="tableClassNoBorder">Certifications:</td></tr><tr class="tableClass"><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder"><div class="text">
									Not Applicable
							</div></td></tr></table><br></div><div class="form1"><table role="presentation" id="signatureInfo"><tr><td width="8%" class="tableClassValignNoBorder">    SIGNATURE</td><td width="92%" class="tableClassNoBorder"> </td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder"><div class="information" style="text-align:justify">
						After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
						<br><br></div></td></tr></table><table><tr class="tableClass"><td width="50%" class="tableClassNoBorder"> </td><td width="50%" class="tableClassNoBorder"><table><tr class="tableClass"><td width="100%" class="tableClassInnerNoBorderBlue"><div class="text">TPG GP A, LLC</div></td></tr></table></td></tr></table><table><tr class="tableClass"><td width="50%" class="tableClassNoBorder"> </td><td width="50%" class="tableClassNoBorder"><table><tr class="tableClass"><td width="8%" class="tableClassNoBorderAlignLeft signature">Signature:</td><td width="92%" class="tableClassNoBorderBlue signature">/s/ Matthew White</td></tr><tr class="tableClass"><td width="8%" class="tableClassNoBorderAlignLeft signature">Name/Title:</td><td width="92%" class="tableClassNoBorderBlue signature">Matthew White / Vice President</td></tr><tr class="tableClass"><td width="8%" class="tableClassNoBorderAlignLeft signature">Date:</td><td width="92%" class="tableClassNoBorderBlue signature">08/14/2026</td></tr></table></td></tr></table><table><tr class="tableClass"><td width="50%" class="tableClassNoBorder"> </td><td width="50%" class="tableClassNoBorder"><table><tr class="tableClass"><td width="100%" class="tableClassInnerNoBorderBlue"><div class="text">COULTER, JAMES G</div></td></tr></table></td></tr></table><table><tr class="tableClass"><td width="50%" class="tableClassNoBorder"> </td><td width="50%" class="tableClassNoBorder"><table><tr class="tableClass"><td width="8%" class="tableClassNoBorderAlignLeft signature">Signature:</td><td width="92%" class="tableClassNoBorderBlue signature">/s/ Gerald Neugebauer</td></tr><tr class="tableClass"><td width="8%" class="tableClassNoBorderAlignLeft signature">Name/Title:</td><td width="92%" class="tableClassNoBorderBlue signature">Gerald Neugebauer on behalf of James G. Coulter (1)</td></tr><tr class="tableClass"><td width="8%" class="tableClassNoBorderAlignLeft signature">Date:</td><td width="92%" class="tableClassNoBorderBlue signature">08/14/2026</td></tr></table></td></tr></table><table><tr class="tableClass"><td width="50%" class="tableClassNoBorder"> </td><td width="50%" class="tableClassNoBorder"><table><tr class="tableClass"><td width="100%" class="tableClassInnerNoBorderBlue"><div class="text">WINKELRIED, JON</div></td></tr></table></td></tr></table><table><tr class="tableClass"><td width="50%" class="tableClassNoBorder"> </td><td width="50%" class="tableClassNoBorder"><table><tr class="tableClass"><td width="8%" class="tableClassNoBorderAlignLeft signature">Signature:</td><td width="92%" class="tableClassNoBorderBlue signature">/s/ Gerald Neugebauer</td></tr><tr class="tableClass"><td width="8%" class="tableClassNoBorderAlignLeft signature">Name/Title:</td><td width="92%" class="tableClassNoBorderBlue signature">Gerald Neugebauer on behalf of Jon Winkelried (2)</td></tr><tr class="tableClass"><td width="8%" class="tableClassNoBorderAlignLeft signature">Date:</td><td width="92%" class="tableClassNoBorderBlue signature">08/14/2026</td></tr></table></td></tr></table><br><div class="largetext"><span style="color:black;font-weight:bold;">Comments accompanying signature:</span>  (1) Gerald Neugebauer is signing on behalf of Mr. Coulter pursuant to an authorization and designation letter dated January 10, 2024, which was previously filed with the Commission as an exhibit to a Form 4 filed by Mr. Coulter on February 7, 2024 (SEC File No. 001-41617).

(2) Gerald Neugebauer is signing on behalf of Mr. Winkelried pursuant to an authorization and designation letter dated January 10, 2024, which was previously filed with the Commission as an exhibit to a Form 4 filed by Mr. Winkelried on February 7, 2024 (SEC File No. 001-41617).</div><table><tr class="tableClass" colspan="2"><td width="100%" class="tableClassNoBorder"><div class="information" style="text-align:center;font-weight:bold;">
					 Exhibit Information
					<br><br></div></td></tr><tr class="tableClass" colspan="2"><td width="100%" class="tableClassNoBorder"><div class="largetext">Exhibit 1 Agreement of Joint Filing as required by Rule 13d-1(k)(1) under the Act.*
* Incorporated herein by reference to the Agreement of Joint Filing by TPG Group Holdings (SBS) Advisors, Inc., TPG GP A, LLC, TPG Advisors VII, Inc., TPG Advisors VI, Inc., TPG Advisors VI-AIV, Inc., TPG Asia Advisors VI, Inc., David Bonderman, James G. Coulter, Jon Winkelried and Karl Peterson dated as of January 18, 2022, which was previously filed with the Securities and Exchange Commission (the "Commission") as Exhibit 1 to Amendment No. 4 to Schedule 13D filed by TPG GP A, LLC, David Bonderman, James G. Coulter and Jon Winkelried on January 18, 2022 with respect to the shares of common stock of Allogene Therapeutics, Inc.<br><br></div></td></tr></table></div></div>
</body></html>
